Cannabidiol for moderate–severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing
Journal of Clinical Sleep Medicine · 2024-05 · 20 (5) · 753-763
DOI: 10.5664/jcsm.10998 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Sleep Medicine, 2024-05. Verfasst von Andrea J Narayan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Mental Health and Brain Sciences, Swinburne University of Technology, Hawthorn, Australia. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Cannabidiol. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaf
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Mental Health and Brain Sciences, Swinburne University of Technology, Hawthorn, Australia.
- Institute for Breathing and Sleep, Austin Hospital, Melbourne, Australia.
Zitieren
APA
Narayan, A. J., Downey, L. A., Rose, S., Di Natale, L., & Hayley, A. C. (2024). Cannabidiol for moderate–severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing. Journal of Clinical Sleep Medicine, 20(5), 753-763. https://doi.org/10.5664/jcsm.10998
Vancouver
Narayan AJ, Downey LA, Rose S, Di Natale L, Hayley AC. Cannabidiol for moderate–severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing. Journal of Clinical Sleep Medicine. 2024;20(5):753-763. doi:10.5664/jcsm.10998
BibTeX
@article{Narayan2024,
author = {Narayan, Andrea J and Downey, Luke A and Rose, Sarah and Di Natale, Lauren and Hayley, Amie C},
title = {Cannabidiol for moderate–severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing},
journal = {Journal of Clinical Sleep Medicine},
year = {2024},
volume = {20},
number = {5},
pages = {753--763},
doi = {10.5664/jcsm.10998}
}
EUVIMED